182 related articles for article (PubMed ID: 34399788)
1. Effects of EFNA1 on cell phenotype and prognosis of esophageal carcinoma.
Zhang Y; Zhang J; Pan G; Guan T; Zhang C; Hao A; Li Y; Ren H
World J Surg Oncol; 2021 Aug; 19(1):242. PubMed ID: 34399788
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of NOLC1 Inhibits PI3K-AKT Pathway to Improve the Poor Prognosis of Esophageal Carcinoma.
Kong F; Shang Y; Diao X; Huang J; Liu H
J Oncol; 2021; 2021():9944132. PubMed ID: 34046062
[TBL] [Abstract][Full Text] [Related]
3. Bridging Integrator 3 (BIN3) Downregulation Predicts a Poor Prognosis in Patients with Esophagus Carcinoma: A Study based on TCGA Data.
Li D; Deng W; Huang G; Xiao X
Comb Chem High Throughput Screen; 2023; 26(11):1974-1989. PubMed ID: 36475339
[TBL] [Abstract][Full Text] [Related]
4. Caprin-1 plays a role in cell proliferation and Warburg metabolism of esophageal carcinoma by regulating METTL3 and WTAP.
Gao Y; Yuan L; Ke C; Pei Z; Liu X; Wu R; Kui X; Zhang Y
J Transl Med; 2023 Feb; 21(1):159. PubMed ID: 36855123
[TBL] [Abstract][Full Text] [Related]
5. Integrated Analysis of Hub Genes and Pathways In Esophageal Carcinoma Based on NCBI's Gene Expression Omnibus (GEO) Database: A Bioinformatics Analysis.
Yu-Jing T; Wen-Jing T; Biao T
Med Sci Monit; 2020 Aug; 26():e923934. PubMed ID: 32756534
[TBL] [Abstract][Full Text] [Related]
6. Rhein suppresses esophageal cancer development by regulating cell cycle through DNMT3B gene.
Li C; Yu J; Feng Y; Sun X; Sun M; Ni W; Shao J; Wang B
Med Oncol; 2024 May; 41(6):153. PubMed ID: 38743323
[TBL] [Abstract][Full Text] [Related]
7. High expression of caspase-8 as a predictive factor of poor prognosis in patients with esophageal cancer.
Chai J; Lei Y; Xiang X; Ye J; Zhao H; Yi L
Cancer Med; 2023 Mar; 12(6):7651-7666. PubMed ID: 36533709
[TBL] [Abstract][Full Text] [Related]
8. Screening of four key genes in esophageal carcinoma based on TCGA and GEO data and verification of anti-proliferative effect of LAPTM4B knockdown in esophageal carcinoma cells invitro.
Guo K; Li K
Arch Biochem Biophys; 2022 Oct; 728():109352. PubMed ID: 35863479
[TBL] [Abstract][Full Text] [Related]
9. Construction and investigation of β3GNT2-associated regulatory network in esophageal carcinoma.
Luo Z; Hu Q; Tang Y; Leng Y; Tian T; Tian S; Huang C; Liu A; Deng X; Shen L
Cell Mol Biol Lett; 2022 Jan; 27(1):8. PubMed ID: 35073841
[TBL] [Abstract][Full Text] [Related]
10. Identification of hub necroptosis-related lncRNAs for prognosis prediction of esophageal carcinoma.
Luo Z; Ding E; Yu L; Wang W; Guo Q; Li X; Wang Y; Li T; Zhang Y; Zhang X
Aging (Albany NY); 2023 Jun; 15(11):4794-4819. PubMed ID: 37263709
[TBL] [Abstract][Full Text] [Related]
11. Down-Regulation of miR-2053 Inhibits the Development and Progression of Esophageal Carcinoma by Targeting Fyn-Related Kinase (FRK).
Wang B; Zhang L; Li J; Hua P; Zhang Y
Dig Dis Sci; 2020 Oct; 65(10):2853-2862. PubMed ID: 31894485
[TBL] [Abstract][Full Text] [Related]
12. Highly Expressed Z-DNA Binding Protein 1 in Esophageal Cancer Promotes Tumor Growth.
Wusiman S; Liu Y; Li H; Deng Y; Qu X; Tuerxun H; Liu L
Dig Dis Sci; 2024 May; 69(5):1674-1690. PubMed ID: 38507125
[TBL] [Abstract][Full Text] [Related]
13. Screening and verification of potential gene targets in esophageal carcinoma by bioinformatics analysis and immunohistochemistry.
Wen P; Dayyani F; Tao R; Zhong X
Ann Transl Med; 2022 Jan; 10(2):70. PubMed ID: 35282073
[TBL] [Abstract][Full Text] [Related]
14. PRDX2 plays an oncogenic role in esophageal squamous cell carcinoma via Wnt/β-catenin and AKT pathways.
Feng AL; Han X; Meng X; Chen Z; Li Q; Shu W; Dai H; Zhu J; Yang Z
Clin Transl Oncol; 2020 Oct; 22(10):1838-1848. PubMed ID: 32130676
[TBL] [Abstract][Full Text] [Related]
15. Identification of Autophagy-Related Genes and Small-Molecule Drugs in Esophageal Carcinoma.
Li Z; Dong K; Guo P; Tan Z; Zhang F; Tian Y; Lv H
Med Sci Monit; 2020 May; 26():e921855. PubMed ID: 32415055
[TBL] [Abstract][Full Text] [Related]
16. Targeting EFNA1 suppresses tumor progression via the cMYC-modulated cell cycle and autophagy in esophageal squamous cell carcinoma.
Jiang H; Wang S; Liu Y; Zheng C; Chen L; Zheng K; Xu Z; Dai Y; Jin H; Cheng Z; Zou C; Fu L; Liu K; Ma X
Discov Oncol; 2023 May; 14(1):64. PubMed ID: 37160815
[TBL] [Abstract][Full Text] [Related]
17. Identification and validation of UBE2B as a prognostic biomarker promoting the development of esophageal carcinomas.
Ding H; Xu JC; Ding ZG; Wu LF; Liu YB; Zhang YF; Chen TY; Zhang YQ; Zhou PH
Front Immunol; 2024; 15():1295305. PubMed ID: 38481990
[TBL] [Abstract][Full Text] [Related]
18. Identification of crucial genes correlated with esophageal cancer by integrated high-throughput data analysis.
Zhou W; Wu J; Liu X; Ni M; Meng Z; Liu S; Jia S; Zhang J; Guo S; Zhang X
Medicine (Baltimore); 2020 May; 99(20):e20340. PubMed ID: 32443386
[TBL] [Abstract][Full Text] [Related]
19. DNA methylation data-based prognosis-subtype distinctions in patients with esophageal carcinoma by bioinformatic studies.
Chen H; Qin Q; Xu Z; Chen T; Yao X; Xu B; Sun X
J Cell Physiol; 2021 Mar; 236(3):2126-2138. PubMed ID: 32830322
[TBL] [Abstract][Full Text] [Related]
20. CDKL3 shapes immunosuppressive tumor microenvironment and initiates autophagy in esophageal cancer.
Bi Y; Liu J; Qin S; Ji F; Zhou C; Yang H; Zhou S
Front Immunol; 2024; 15():1295011. PubMed ID: 38562942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
